Y-mAbs names Rossi CEO

Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) named Michael Rossi as president, CEO and director, and Thomas Gad as vice chairman and CBO. Rossi was head of radioligand imaging and led the U.S. business of Advanced Accelerators Applications at Novartis AG (SIX:NOVN; NYSE:NVS). Gad, who founded Y-mAbs in 2015, has served as president and head of business development and strategy since 2015 and interim CEO since 2022. Both appointments are effective Nov. 6. 

Cargo Therapeutics Inc. hired Ginna Laport as CMO. Laport served as VP of clinical development, global head of NHL/CLL franchise, at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). Cargo is developing CAR T-cell therapies to treat cancer. ...